Actavis’ Launch Of Pulmicort Respules Generic Halted By Court
This article was originally published in The Pink Sheet Daily
Executive Summary
One day after declaring one Pulmicort patent invalid and another not infringed, a New Jersey federal judge granted AstraZeneca’s bid to temporarily block Actavis and other ANDA filers from launching and distributing their budesonide generics.